Company intelligence / Profile preview

Shanghai Sanwei Pharmaceutical

Shanghai, Shanghai, China

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Shanghai Sanwei Pharmaceutical is a subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), specializing in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. It is one of China's leading producers of anti-tuberculosis drugs (notably Rifampicin) and Vitamin B12 series products, with extensive manufacturing facilities meeting international GMP standards.

Therapeutic areas: HematologyInfectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Shanghai Sanwei Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Sanwei Pharmaceutical.

Explore the full profile